For the purposes of this Regulation, the definitions in Article 1 of Directive 2001/83/EC shall apply.
The following definitions shall apply:
‘unique identifier’ means the safety feature enabling the verification of the authenticity and the identification of an individual pack of a medicinal product;
‘anti-tampering device’ means the safety feature allowing the verification of whether the packaging of a medicinal product has been tampered with;
‘decommissioning of a unique identifier’ means the operation changing the active status of a unique identifier stored in the repositories system referred to in Article 31 of this Regulation to a status impeding any further successful verification of the authenticity of that unique identifier;
‘active unique identifier’ means a unique identifier which has not been decommissioned or which is no longer decommissioned, and which has not been identified as a ‘non-Union pack’ as referred to in Article 36, point (p);
‘active status’ means the status of an active unique identifier stored in the repositories system referred to in Article 31;
‘healthcare institution’ means a hospital, in- or outpatient clinic or health centre.